Atypical Toxoplasma gondii strains, unrelated to archetypal clonal lineages (I, II, III), have been reported more frequently over the last decade in areas other than Europe and North America. A newly described form of toxoplasmosis, 'Amazonian toxoplasmosis' (AT), has been reported since 2002 in French Guiana. It is characterized by severe cases and atypical strains linked to a neotropical forest-based cycle. We report on the cases of AT that required intensive care management. We performed a prospective observational study on hospitalized adults in the Intensive Care Unit (ICU) from 2002 to 2008. Clinical and laboratory data, microbiological findings and outcomes were recorded. Data, including the ICU simplified acute physiology score and the pneumonia severity index, were calculated. Epidemiological risk factors for AT were assessed through questionnaires. Eleven non-immunodeficient patients were admitted to the ICU in Cayenne for life-threatening pneumonia associated with disseminated toxoplasmosis. Mechanical ventilation was necessary in seven patients, four of whom required immediate orotracheal intubation. Cardiac and ophthalmological abnormalities were found in five and four patients, respectively. One patient died from multiple organ failure. The genetic characterization of Toxoplasma DNA using six microsatellite markers revealed unique and atypical genotypes in eight patients. All patients presented epidemiological risk factors for AT. In French Guiana, significant T. gondii-related infectious syndrome associated with the lungs, a high level of LDH activity and the reported risk factors for AT was strongly suggestive of disseminated toxoplasmosis with a possible trend toward life-threatening pneumonia.
Introduction
Some reports from South America suggest a higher human pathogenicity [1] [2] [3] [4] of newly discovered genotypes of T. gondii. Particular epidemiological and bioclinical features have been reported during individual infections or community outbreaks in immunocompetent adults and children in French Guiana and Suriname since 1998 [5] [6] [7] . All the strains isolated had atypical genotypes and appeared to be linked to a neotropical forest-based cycle involving wild felids and their prey [8] [9] [10] . These case reports helped to define a new form of toxoplasmosis, ''Amazonian toxoplasmosis'' (AT). Through 11 case reports, we describe the most severe form of AT, a disseminated toxoplasmosis with life-threatening pneumonia, occurring in French Guianese adults from 2002 to 2008. Each patient required intensive care management, as they displayed at least one form of organ failure.
Materials and Methods

Study site
This study was performed in the ten-bed medical-surgical Intensive Care Unit (ICU) of Cayenne Hospital in French Guiana, which is a French overseas department of 220 000 inhabitants neighbouring Brazil and Suriname in the Amazonian region.
Patient selection
A prospective analysis was carried out on all consecutive adult non-immunodeficient patients that were admitted to the Cayenne Hospital ICU and diagnosed with acute toxoplasmosis from 2002 to 2008.
Data
Data were collected from patient medical records: (i) general demographic data; (ii) laboratory analysis, microbiology, radiology variables and additional explorations such as ophthalmological examinations (for nine patients) and/or cardiac ultrasonography (for ten patients) depending on the signs; and (iii) the reasons for admission to the ICU, the hospital and ICU length of stay (LOS), the ICU scoring system at admission, and the life-support treatment and drugs prescribed in the ICU. Epidemiological risk factors for AT (biotope of residence, meat-borne risk factors and contact with forestry elements) were obtained from individual patients through interviews when possible or from the patient's family. All patients and/or relatives gave informed consents.
Toxoplasmosis diagnosis
Acute toxoplasmosis was defined as serological evidence of recent Toxoplasma infection corresponding to the presence of Toxoplasma-specific IgM with seroconversion or a significant increase in IgG anti-Toxoplasma antibody titres. Patient serum samples were analysed using an enzyme immunoassay (EIA) kit to detect Toxoplasma-specific IgG and IgM (Abbott Diagnostics, Abbott Park, IL, USA). Patient specimens (12 blood samples, five pulmonary fluids, one pleural fluid and one muscular biopsy) were sent for DNA analysis to the National Reference Center for Toxoplasmosis (Limoges, France) 3-14 days after collection. A Qiagen DNA Mini Kit (Hilden, Germany) was used to extract DNA from these samples and a PCR-based assay was performed to detect the T. gondii B1 gene [11] . Toxoplasma DNA for genotyping was extracted directly from bronchoalveolar lavage (BAL) or bronchial aspiration (BA) samples (cases no. 4, 5 and 10) and indirectly from infected mouse ascitic fluid after the inoculation of blood samples (cases no. 1, 2, 6, 8 and 11). DNA was genotyped by comparing length polymorphisms in six microsatellite markers (TUB2, W35, TgM-A, B18, B17 and M33), as described elsewhere [12] .
Medical and ICU scoring systems
We calculated the ICU Simplified Acute Physiology Score (SAPS II) during the first 24 h of admission [13] . This point scale, ranging from zero to 163, corresponds to a predicted mortality between 0% and 100%. The pneumonia severity index (PSI) is used to classify the severity of a patient's community-acquired pneumonia (CAP) before ICU admission as described by Fine et al. [14] , and make appropriate site-ofcare decisions. Patients can be stratified into five risk categories (risk classes I-V) that are used to predict 30-day survival.
Retroviral investigation
All patients were tested for HIV serological status using two HIV tests by EIA (Abbott, Biorad, Hercules, CA, USA or Biomérieux, Marcy l'Etoile, France). The Murex HTLV-1/2 EIA test (Abbott) was used to screen for human T lymphotropic virus status.
Microbiology differential diagnosis
Additional tests, including serological tests, direct examination, media culture or PCR-based tests were performed on patients' samples (blood, cerebrospinal fluid, BAL, sputum and gastric aspirations) for differential diagnosis: malaria, tuberculosis, Q fever, leptospirosis, infection with Chlamydia sp, Mycoplasma pneumoniae, Legionella pneumophila, Rickettsia sp, Pneumocystis sp, Histoplasma capsulatum or other exotic fungi, Epstein-Bar virus, cytomegalovirus, respiratory syncytial virus and arbovirus. Bronchoscopic samples were obtained based on clinical features and CAP management guidelines. Cytology was performed on BAL from seven patients.
Results
From January 2002 to December 2008, 11 patients were admitted to the Cayenne Hospital ICU for life-threatening pneumonia with disseminated toxoplasmosis. Two of the 11 patients had been previously described by Carme et al. [6] .
Epidemiological description of the study population
The median age was 28 years (range, 18-41) and there was a predominance of men (nine patients) and Maroon people (seven patients) ( Table 1 and Fig. 1 ). Eight patients were permanently living in the forest, but all presented risk factors for AT in the 2 weeks before the onset of symptoms. Dietary risk factors were reported for eight patients, and the animal eaten was clearly identified in four patients. Meat consumption was regular in cases 1, 3 and 6, making it difficult to reliably identify which type of meat was responsible for the infection. Environmental risk factors for patient 2 were clearly identified, as he was a vegetarian and a healer, and thus was used to handling plants from the forest.
Medical characteristics of patients
None of the other patients presented relevant medical history, except one patient who had homozygous sickle cell disease (case 1) (Tables 2 and 3 ). The main clinical presentation consisted of a sudden, significant non-specific infectious syndrome with (i) a history of high (median value of 40°C), prolonged (lasting more than 15 days) and continuous fever, (ii) a slow major general decrease in health with progressive weight loss, anorexia and weakness that started with the onset of symptoms, and (iii) lung involvement. Hepatomegaly, splenomegaly or lymph node enlargement was found, and cardiac or ophthalmological abnormalities were described in five and four patients, respectively. One patient had anasarca with hemodynamic instability. The patient's initial symptoms quickly developed into a severe sepsis-like infection, mainly associated with acute respiratory distress, requiring referral to the ICU in Cayenne. Haemodynamic instability with septic shock, renal insufficiency or hepatic insufficiency occurred in three, one and one patients, respectively. Five patients had an ICU SAPS II score that was >30 and a predicted mortality that was >12%; this was especially apparent in the patient that died (predicted mortality, 43.8%). 10 (14) 4 (20) 4 (21) 28 (57) 13 (33) 6 (40) 4 (36) 15 (55) 6 (43) 8 (40) 4 ( For all patients, lung involvement started progressively with a dry cough and chest pain during the first 2 weeks of disease (Table 3 , Photos 1 and 2). Clinical examinations revealed unilateral or bilateral crackles, unilateral bronchial breathing or areas of dullness. It quickly developed into respiratory insufficiency with acute dyspnoea, and significant abnormality in the blood gas values. Nine patients presented a PSI score that corresponded to risk class IV or above; thus, patients had between a 9.3% and 27% risk of death within 30 days. According to the North American-European Consensus Committee (NAECC) [15] , patients 1 and 6 suffered from acute lung injury (ALI), whereas the other patients had acute respiratory distress syndrome (ARDS) on admission to the ICU. All patients presented serological evidence of recent Toxoplasma infection (Table 4) . Although patient 4 displayed seroconversion with the appearance of Toxoplasma-specific IgM and IgG in a second sample, the other patients presented significant changes to Toxoplasma-specific IgG and IgM values over a short period of time. Humoral response was characterized by high IgM index values in all patients and hypergammaglobulinaemia in five patients (not shown). Molecular diagnosis confirmed T. gondii infection in eight patients (Table 4 ). The muscle biopsy (case 5) was positive even though the patient had been receiving treatment for 22 days. Genotype analysis of Toxoplasma DNA samples from eight patients revealed atypical (unusual alleles at loci, shuffled combination of classical and/or unusual alleles) and unique multilocus genotypes.
Treatment and outcome
All patients received antibiotics immediately, which included beta-lactams, fluoroquinolones, macrolides, and more or less aminoglycosides due to the severity of symptoms (Table 4 ). All patients received oral sulfadiazine and pyrimethamine for a mean period of 42.4 days, except patient 11 who died on day 6 after the start of this treatment. This patient had been treated for longer than a month after the onset of symptoms, unlike the other patients, who received treatment for only 2-3 weeks following the onset of symptoms. All patients except patient 11, who died with a multiple organ dysfunction syndrome, recovered after the initiation of sulfadiazine and pyrimethamine therapy. Side-effects due to sulfadiazine were reported in two patients (cases 4 and 7), requiring replacement with clindamycin. Three patients whilst under treatment developed signs consistent with toxoplasmosis infection: (i) cerebral oedema without focal lesions on day 5 of sulfadiazine/pyrimethamine treatment (patient 4), (ii) intense polymyositis on day 16 of treatment requiring oral corticoids (patient 5), and (iii) unusual hyperprolactinaemia and galactorrhea with no other hormonal or cerebral abnormalities (patient 9). The appearance of long-lasting apyrexia was delayed due to nosocomial infections (patients 1 and 4) and complications such as phlebitis and pulmonary emboly (patient 1). In addition to sulfadiazine/pyrimethamine treatment, patients received ICU treatment based on the type of organ dysfunction. Four patients required a high-concentration oxygen mask, and mechanical ventilation was required by seven patients, four of whom received tracheal intubation. Patients received these non-specific treatments over short periods, lasting no more than 4 days, except for patient 4, who required 16 days of mechanical ventilation (tracheal intubation and non-invasive ventilation). Long-term follow-up was possible in eight patients. Patient 2 presented three typical, active unilateral retinochoroiditis foci 6 years after the acute infection; HIV and HTLV1-2 remained negative. No complications were identified among the other patients.
Discussion
Since 1998, 65 cases of AT have been reported [5, 6 , M. Demar, personal communication] in French Guiana. They involve wild T. gondii strains that circulate in this Amazonian area between wild felids (definitive hosts), their prey (intermediate hosts) and humans (accidental hosts) [5] . These strains exhibit an atypical and unique multilocus genotype and present an unusual virulence in mice upon primary isolation [6] [7] [8] [9] [10] . At the same time, little was known about the genotypes of strains causing chronic and asymptomatic toxoplasmosis as they have silent expression in immunocompetent adults. The seroprevalence of uncomplicated toxoplasmosis was estimated at 72% among 179 adults hospitalized for reasons other than acute toxoplasmosis from 1999 to 2001 [6] . A recent genetic study, including large numbers of T. gondii isolates from domestic and wild animals and from patients suffering with AT, genetically individualized the 'anthropized' and the 'wild' T. gondii environmental population with respectively low and high genetic diversity [16] . Genotypes from both environments cannot be classified into the three main lineages described in North America or Europe. AT presented as a significant infectious syndrome with enlargement of the liver, the spleen and/or the lymph nodes. Even though other organs can be affected such as the heart, central nervous system (CNS) or eyes, the prognosis is linked to lung involvement, which has been consistently reported with variable levels of severity [5, 6] . Our series of 11 French Guianese patients with disseminated toxoplasmosis underscores the central role of life-threatening pneumonia. Molecular typing of isolates confirmed their unique and divergent genotypes. Clinical history was consistent with an acute increase in pulmonary signals up to respiratory distress syndrome associated with severe sepsis-like infection. Heart, eye and/or muscle impairment emphasized this severity that has only previously been reported in immunocompromised patients [17] [18] [19] . Moreover, patients should be monitored regularly for the rest of their lives, due to the possible reactivation in immunodeficient and non-immunodeficient patients. Despite recent findings in mouse experimental models [20] , pulmonary involvement during Toxoplasma infection is rare in immunocompetent subjects. It is mainly observed in immunocompromised patients [12, [17] [18] [19] [21] [22] [23] . Pomeroy and Filice [22] reviewed 46 cases of Toxoplasma pneumonia, of which 15 were among non-immunodeficient patients. This has been followed by recent sporadic reports [6, [24] [25] [26] [27] .
Neither pulmonary symptoms nor specific findings on chest radiography were found to distinguish Toxoplasma pneumonia from pneumonia due to more common pathogens. A high level of LDH can be an adjunctive marker, as previously discussed [28] . Diagnosis was usually established by visualizing tachyzoites in lung tissue or fluids; however, the sensitivity of the method is inconsistent [29, 30] and may be dependent on the amount of T. gondii in specimens. PCR analysis is increasingly regarded as the most sensitive method for the diagnosis of Toxoplasma pneumonia [12] ; this was similarly observed in our series. In addition, blood seemed to be most suitable for detecting T. gondii, even 30 days after infection onset (cases 8, 11). The T. gondii infection had spread to the lungs, inducing necrotizing pneumonitis [31] , mostly as part of toxoplasmosis dissemination to multiple organs via parasitaemia, which can lead to septic shock. Wild Amazonian strains appear to be more aggressive with specific pulmonary tropism. This particular clinical feature may also be the result of an overstimulation of immune response, the human immune system being unsuited to such strains. So far, no particular predisposing factors for T. gondii lung involvement have been described elsewhere.
Several hypotheses, other than those relating to virulent strains, can be suggested to explain this severity. (i) A delay in introducing disease management (i.e. patient 11, who died, did not received adequate care early enough). Indeed, patients that survived, despite increased severity (SAPS II, PSI), were managed within 2-3 weeks after the onset of symptoms (patients 3, 4, 5 and 7). (ii) Toxoplasma gondii parasitic stage (i.e. ingestion of oocysts). All patients displayed several risk factors for toxoplasmosis exposure. Unfortunately, none of these risk factors allowed the identification of the infective stage, except in patient 2, who was vegetarian. (iii) Host susceptibility; however, except for patient 1 who had sickle cell disease, well-known to promote complications in infection, no other patients had predisposing factors and almost all ethnic groups were represented. The inoculum effect may also be mentioned. One of the most severely ill patients (patient 4) consumed pieces of raw game meat (carpaccio), which could contain a significant amount of living parasites. However, this couldn't be proved as no pathological or molecular studies have been carried out on meat. Further in vivo investigation is essential to understand the basic mechanism of virulence of these novel isolates.
Conclusion
Although AT remains prevalent in French Guiana, the number of new life-threatening cases has decreased since 2004 (nine patients reported from 2002 to 2004 vs. two patients from 2005 to 2010; M. Demar, unpublished data), probably due to the population and physician awareness. AT is well known in French Guiana and physicians should be aware of such severe cases of acquired toxoplasmosis, which should be suspected in any lung infections with a long lasting high fever in patients who live in or have recently visited the Amazonian region or more generally the neotropical rain forest.
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